SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk
SOXL 55.41-1.2%Jan 14 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: golfer72 who wrote (186484)2/19/2023 9:02:24 PM
From: TigerPaw  Read Replies (4) of 207796
 
This "vaccine" is different.

Your are correct. The MRNA technology is an extremely targeted approach to delivering drugs to an individual. By using the person's own RNA mechanisms to synthesize the payload it makes it much more likely that the final payload is completely compatible with that person's body chemistry. The old technology of drug manufacture had to create a general purpose protean that may or may not be compatible with the individuals specific body. The MRNA provides a blueprint for the drug, not the actual drug, and lets the body create the drug using it's own mechanisms. The resulting drug has been produced by the same RNA process that the body uses to produce all it's internal chemistry.

This is why the also-ran pharma companies are so afraid that they will not be able to compete with this technology. This is why they pay think-tanks to find ways to slow down the advancement before the also-ran pharma become completely irrelevant. This is why the think tanks either dupe the ill informed to write their nonsense or pay the unethical to write their nonsense. There is a lot of money at stake in the old one drug for all, or the new drugs tailored by the patients own cells to create a drug better suited to that individual.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News